Akebia therapeutics reports inducement grants under nasdaq listing rule 5635(c)(4)

Cambridge, mass. , jan. 2, 2025 /prnewswire/ -- akebia therapeutics®, inc. (nasdaq: akba), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to purchase an aggregate of 3,000 shares of akebia's common stock on december 31, 2024.

NDAQ Ratings Summary

NDAQ Quant Ranking